APA (7th ed.) Citation

Katsuyama, H., Hakoshima, M., Umeyama, S., Iida, S., Adachi, H., & Yanai, H. (2023). Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study. MDPI AG.

Chicago Style (17th ed.) Citation

Katsuyama, Hisayuki, Mariko Hakoshima, Shohei Umeyama, Sakura Iida, Hiroki Adachi, and Hidekatsu Yanai. Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study. MDPI AG, 2023.

MLA (9th ed.) Citation

Katsuyama, Hisayuki, et al. Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study. MDPI AG, 2023.